AU3882200A - A chc biosynthetic gene cluster - Google Patents
A chc biosynthetic gene clusterInfo
- Publication number
- AU3882200A AU3882200A AU38822/00A AU3882200A AU3882200A AU 3882200 A AU3882200 A AU 3882200A AU 38822/00 A AU38822/00 A AU 38822/00A AU 3882200 A AU3882200 A AU 3882200A AU 3882200 A AU3882200 A AU 3882200A
- Authority
- AU
- Australia
- Prior art keywords
- chc
- gene cluster
- biosynthetic gene
- biosynthetic
- cluster
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
- C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
- C12P19/623—Avermectin; Milbemycin; Ivermectin; C-076
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12464899P | 1999-03-16 | 1999-03-16 | |
US60124648 | 1999-03-16 | ||
US15293099P | 1999-09-09 | 1999-09-09 | |
US60152930 | 1999-09-09 | ||
PCT/US2000/006651 WO2000055304A2 (en) | 1999-03-16 | 2000-03-15 | A chc biosynthetic gene cluster |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3882200A true AU3882200A (en) | 2000-10-04 |
Family
ID=26822816
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU38822/00A Abandoned AU3882200A (en) | 1999-03-16 | 2000-03-15 | A chc biosynthetic gene cluster |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3882200A (en) |
WO (1) | WO2000055304A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104694600B (en) * | 2015-03-24 | 2015-11-25 | 杨玉淮 | Stable fermentation process and doractin composition thereof |
CN109234194B (en) * | 2018-09-26 | 2021-08-24 | 武汉回盛生物科技股份有限公司 | Doramectin producing strain and application thereof |
CN109576196B (en) * | 2019-01-25 | 2022-01-04 | 北大方正集团有限公司 | Fermentation medium for producing doramectin and production method of doramectin |
-
2000
- 2000-03-15 WO PCT/US2000/006651 patent/WO2000055304A2/en active Application Filing
- 2000-03-15 AU AU38822/00A patent/AU3882200A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2000055304A2 (en) | 2000-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3111800A (en) | A computer implemented method | |
AU3369900A (en) | Gene silencing | |
AUPP826999A0 (en) | A mounting arrangement | |
AU3876300A (en) | Mitomycin biosynthetic gene cluster | |
AUPQ262599A0 (en) | Gene expression | |
AU2001227903A1 (en) | Everninomicin biosynthetic genes | |
AU5310500A (en) | Pseudomycin prodrugs | |
AU8018200A (en) | A knowledge-engineering protocol-suite | |
AU3882200A (en) | A chc biosynthetic gene cluster | |
AU2376200A (en) | Insulin-synthesis genes | |
AU4303701A (en) | Method for supporting a wall | |
AU5016200A (en) | Diabetes gene | |
AU7921200A (en) | A new EAG gene | |
AU4132500A (en) | A computer interface | |
AU6871900A (en) | Tsg-like gene | |
AU1870000A (en) | Gene therapy-2 | |
AU7793000A (en) | Access control of a service | |
AU2001231457A1 (en) | Genetic locus for everninomicin biosynthesis | |
AU4144600A (en) | Cyp2a6 gene judgment methods | |
AU6329400A (en) | Arrangement for a brassiere | |
AUPP470898A0 (en) | A regulatory gene | |
AU6333700A (en) | Zwittermicin a biosynthetic gene from bacillus cereus | |
AU4552700A (en) | Gene therapy | |
AU6278399A (en) | Tsg-5: a tnf-inducible gene | |
AU7789000A (en) | A method for the generation of repeat-depleted dna |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |